279 related articles for article (PubMed ID: 32909732)
1. A Hepatocellular Carcinoma Targeting Nanostrategy with Hypoxia-Ameliorating and Photothermal Abilities that, Combined with Immunotherapy, Inhibits Metastasis and Recurrence.
Zhou T; Liang X; Wang P; Hu Y; Qi Y; Jin Y; Du Y; Fang C; Tian J
ACS Nano; 2020 Oct; 14(10):12679-12696. PubMed ID: 32909732
[TBL] [Abstract][Full Text] [Related]
2. Hybrid membrane camouflaged copper sulfide nanoparticles for photothermal-chemotherapy of hepatocellular carcinoma.
Ji B; Cai H; Yang Y; Peng F; Song M; Sun K; Yan F; Liu Y
Acta Biomater; 2020 Jul; 111():363-372. PubMed ID: 32434082
[TBL] [Abstract][Full Text] [Related]
3. Enhancing anti-tumor efficiency in hepatocellular carcinoma through the autophagy inhibition by miR-375/sorafenib in lipid-coated calcium carbonate nanoparticles.
Zhao P; Li M; Wang Y; Chen Y; He C; Zhang X; Yang T; Lu Y; You J; Lee RJ; Xiang G
Acta Biomater; 2018 May; 72():248-255. PubMed ID: 29555460
[TBL] [Abstract][Full Text] [Related]
4. Biomimetic black phosphorus quantum dots-based photothermal therapy combined with anti-PD-L1 treatment inhibits recurrence and metastasis in triple-negative breast cancer.
Zhao P; Xu Y; Ji W; Zhou S; Li L; Qiu L; Qian Z; Wang X; Zhang H
J Nanobiotechnology; 2021 Jun; 19(1):181. PubMed ID: 34120612
[TBL] [Abstract][Full Text] [Related]
5. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
6. Ataxia telangiectasia mutated inhibitor-loaded copper sulfide nanoparticles for low-temperature photothermal therapy of hepatocellular carcinoma.
Cai H; Dai X; Guo X; Zhang L; Cao K; Yan F; Ji B; Liu Y
Acta Biomater; 2021 Jun; 127():276-286. PubMed ID: 33812073
[TBL] [Abstract][Full Text] [Related]
7. Selective targeting of tumor cells and tumor associated macrophages separately by twin-like core-shell nanoparticles for enhanced tumor-localized chemoimmunotherapy.
Wang T; Zhang J; Hou T; Yin X; Zhang N
Nanoscale; 2019 Aug; 11(29):13934-13946. PubMed ID: 31305839
[TBL] [Abstract][Full Text] [Related]
8. Co-delivery of sorafenib and metapristone encapsulated by CXCR4-targeted PLGA-PEG nanoparticles overcomes hepatocellular carcinoma resistance to sorafenib.
Zheng N; Liu W; Li B; Nie H; Liu J; Cheng Y; Wang J; Dong H; Jia L
J Exp Clin Cancer Res; 2019 May; 38(1):232. PubMed ID: 31151472
[TBL] [Abstract][Full Text] [Related]
9. Promoting Early Diagnosis and Precise Therapy of Hepatocellular Carcinoma by Glypican-3-Targeted Synergistic Chemo-Photothermal Theranostics.
Mu W; Jiang D; Mu S; Liang S; Liu Y; Zhang N
ACS Appl Mater Interfaces; 2019 Jul; 11(26):23591-23604. PubMed ID: 31179679
[TBL] [Abstract][Full Text] [Related]
10. Novel small molecular dye-loaded lipid nanoparticles with efficient near-infrared-II absorption for photoacoustic imaging and photothermal therapy of hepatocellular carcinoma.
Chen Q; Chen J; He M; Bai Y; Yan H; Zeng N; Liu F; Wen S; Song L; Sheng Z; Liu C; Fang C
Biomater Sci; 2019 Aug; 7(8):3165-3177. PubMed ID: 31123730
[TBL] [Abstract][Full Text] [Related]
11. Cell-penetrating Peptide-modified Targeted Drug-loaded Phase-transformation Lipid Nanoparticles Combined with Low-intensity Focused Ultrasound for Precision Theranostics against Hepatocellular Carcinoma.
Zhao H; Wu M; Zhu L; Tian Y; Wu M; Li Y; Deng L; Jiang W; Shen W; Wang Z; Mei Z; Li P; Ran H; Zhou Z; Ren J
Theranostics; 2018; 8(7):1892-1910. PubMed ID: 29556363
[No Abstract] [Full Text] [Related]
12. Targeting the tumor microenvironment with amphiphilic near-infrared cyanine nanoparticles for potentiated photothermal immunotherapy.
Noh I; Son Y; Jung W; Kim M; Kim D; Shin H; Kim YC; Jon S
Biomaterials; 2021 Aug; 275():120926. PubMed ID: 34147723
[TBL] [Abstract][Full Text] [Related]
13. SP94 Peptide-Functionalized PEG-PLGA Nanoparticle Loading with Cryptotanshinone for Targeting Therapy of Hepatocellular Carcinoma.
Nie X; Liu Y; Li M; Yu X; Yuan W; Huang S; Ren D; Wang Y; Wang Y
AAPS PharmSciTech; 2020 Apr; 21(4):124. PubMed ID: 32342227
[TBL] [Abstract][Full Text] [Related]
14. Synergistic triple-combination therapy with hyaluronic acid-shelled PPy/CPT nanoparticles results in tumor regression and prevents tumor recurrence and metastasis in 4T1 breast cancer.
Sun W; Du Y; Liang X; Yu C; Fang J; Lu W; Guo X; Tian J; Jin Y; Zheng J
Biomaterials; 2019 Oct; 217():119264. PubMed ID: 31260883
[TBL] [Abstract][Full Text] [Related]
15. A facile boronophenylalanine modified polydopamine dual drug-loaded nanoparticles for enhanced anti-tumor immune response in hepatocellular carcinoma comprehensive treatment.
Yang F; Dai L; Shi K; Liu Q; Pan M; Mo D; Deng H; Yuan L; Lu Y; Pan L; Yang T; Qian Z
Biomaterials; 2024 Mar; 305():122435. PubMed ID: 38150771
[TBL] [Abstract][Full Text] [Related]
16. Amphiphilic Janus nanoparticles for imaging-guided synergistic chemo-photothermal hepatocellular carcinoma therapy in the second near-infrared window.
Chen X; Zhang X; Zhang L; Gao Y; Wang C; Hong W; Zhao G; Li L; Liu R; Wang C
Nanoscale; 2021 Feb; 13(7):3974-3982. PubMed ID: 33595029
[TBL] [Abstract][Full Text] [Related]
17. Anti-GPC3 antibody-modified sorafenib-loaded nanoparticles significantly inhibited HepG2 hepatocellular carcinoma.
Tang X; Chen L; Li A; Cai S; Zhang Y; Liu X; Jiang Z; Liu X; Liang Y; Ma D
Drug Deliv; 2018 Nov; 25(1):1484-1494. PubMed ID: 29916268
[TBL] [Abstract][Full Text] [Related]
18. Photothermal-Chemotherapy Enhancing Tumor Immunotherapy by Multifunctional Metal-Organic Framework Based Drug Delivery System.
Ni W; Wu J; Fang H; Feng Y; Hu Y; Lin L; Chen J; Chen F; Tian H
Nano Lett; 2021 Sep; 21(18):7796-7805. PubMed ID: 34516141
[TBL] [Abstract][Full Text] [Related]
19. Targeted polypyrrole nanoparticles for the identification and treatment of hepatocellular carcinoma.
Jin Y; Yang X; Tian J
Nanoscale; 2018 May; 10(20):9594-9601. PubMed ID: 29745953
[TBL] [Abstract][Full Text] [Related]
20. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
